Skyline Medical Inc. (NASDAQ:SKLN) Files An 8-K Other EventsItem 8.01. Other Events.
On August 9, 2017, Skyline Medical, Inc. announced that it entered into a definitive Agreement and Plan of Merger with CytoBioscience, Inc. A copy of the press release is attached as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
| Exhibit Number | Description |
| 99.1 | Press release dated August 9, 2017 |
Skyline Medical Inc. ExhibitEX-99.1 2 exh_991.htm PRESS RELEASE EdgarFilingEXHIBIT 99.1Skyline Medical Signs Definitive Merger Agreement With CytoBioscience Conference call begins at 11:00 a.m. Eastern time on August 15 Definitive Merger Agreement signed,…To view the full exhibit click here
About Skyline Medical Inc. (NASDAQ:SKLN)
Skyline Medical Inc. is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed. The Company also manufactures and sells two disposable products required for system operation: a bifurcated single procedure filter and tissue trap, and a single use bottle of cleaning solution. Both items are used on a single procedure basis. Its STREAMWAY Automated Surgical Fluid Waste Management System (FMS) is a wall mounted automated system that disposes of an unlimited amount of suctioned fluid from the patient using standard surgical tubing. The FMS suctions surgical waste fluid from the patient using standard surgical tubing.